Yu-Liang Ran (Yuliang Ran)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

High Efficiency

Signaling Pathway

Small Cell Lung Cancer

Top Venues

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Cell death discovery

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Shiya Liu, Gaigai Shen, Xuanyu Zhou, Lixin Sun, Long Yu, Yuanting Cao, Xiong Shu, Yu-Liang Ran
Hsp90 Promotes Gastric Cancer Cell Metastasis and Stemness by Regulating the Regional Distribution of Glycolysis-Related Metabolic Enzymes in the Cytoplasm. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Xianteng Wang, Xingkai Li, Liman Niu, Fang Lv, Ting Guo, Yushun Gao, Yu-Liang Ran, Weiren Huang, Bing Wang
FAK-LINC01089 negative regulatory loop controls chemoresistance and progression of small cell lung cancer. Oncogene 43 (22) (2024)
Xianteng Wang, Xingkai Li, Liman Niu, Fang Lv, Ting Guo, Yushun Gao, Yu-Liang Ran, Weiren Huang, Bing Wang
FAK-LINC01089 negative regulatory loop controls chemoresistance and progression of small cell lung cancer. Oncogene 43 (22) (2024)
Xianteng Wang, Xingkai Li, Liman Niu, Fang Lv, Ting Guo, Yushun Gao, Yu-Liang Ran, Weiren Huang, Bing Wang
FAK-LINC01089 negative regulatory loop controls chemoresistance and progression of small cell lung cancer. Oncogene (2024)
Xiong Shu, Meng Chen, Shi-Ya Liu, Long Yu, Li-Xin Sun, Li-Chao Sun, Yu-Liang Ran
Palladin promotes cancer stem cell-like properties in lung cancer by activating Wnt/Β-Catenin signaling. Cancer medicine (2022)
Meng Chen, Li-Xin Sun, Long Yu, Jun Liu, Li-Chao Sun, Zhi-Hua Yang, Xiong Shu, Yu-Liang Ran
MYH9 is crucial for stem cell-like properties in non-small cell lung cancer by activating mTOR signaling. Cell death discovery 7 (1) (2021)